ABSTRACT
A 12-year-old French bulldog presented with a mass on the right lower jaw. Computed tomography revealed that the mass originated from the salivary gland and was not continuous with the right mandible. The mass was surgically removed and subsequently diagnosed as extraskeletal osteosarcoma of the salivary gland following histopathological and immunohistochemical examinations. Although the surgical margin was clear, postoperative adjuvant therapy with nonsteroidal anti-inflammatory drugs (NSAIDs) was initiated. Lung metastasis was observed 249 days after the initial examination; therefore, toceranib was initiated with NSAIDs. The dog died 496 days after the initial examination of this disease progression but had good long-term management with a combination of surgery, NSAIDs, and toceranib.
Subject(s)
Bone Neoplasms , Dog Diseases , Osteosarcoma , Soft Tissue Neoplasms , Dogs , Animals , Osteosarcoma/surgery , Osteosarcoma/veterinary , Soft Tissue Neoplasms/veterinary , Anti-Inflammatory Agents, Non-Steroidal , Bone Neoplasms/veterinary , Salivary Glands/diagnostic imaging , Salivary Glands/surgery , Salivary Glands/pathology , Dog Diseases/diagnostic imaging , Dog Diseases/drug therapy , Dog Diseases/surgeryABSTRACT
The nuclear receptors liver X receptor α (LXRα) and LXRß are lipid sensors that regulate lipid metabolism and immunity. Natural killer T (NKT) cells, a T cell subset expressing surface markers of both natural killer cells and T lymphocytes and involved in antitumor immunity, are another abundant immune cell type in the liver. The potential function of the metabolic regulators LXRα/ß in hepatic NKT cells remains unknown. In this study, we examined the role of LXRα and LXRß in NKT cells using mice deficient for LXRα and/or LXRß, and found that hepatic invariant NKT (iNKT) cells are drastically decreased in LXRα/ß-KO mice. Cytokine production stimulated by the iNKT cell activator α-galactosylceramide was impaired in LXRα/ß-KO hepatic mononuclear cells and in LXRα/ß-KO mice. iNKT cell-mediated antitumor effect was also disturbed in LXRα/ß-KO mice. LXRα/ß-KO mice transplanted with wild-type bone marrow showed decreased iNKT cells in the liver and spleen. The thymus of LXRα/ß-KO mice showed a decreased population of iNKT cells. In conclusion, LXRα and LXRß are essential for NKT cell-mediated immunity, such as cytokine production and hepatic antitumor activity, and are involved in NKT cell development in immune tissues, such as the thymus.
Subject(s)
Antineoplastic Agents/pharmacology , Killer Cells, Natural/metabolism , Liver X Receptors/metabolism , Liver/drug effects , Animals , Bone Marrow/metabolism , Bone Marrow Transplantation , Cytokines/metabolism , Galactosylceramides/metabolism , Leukocytes, Mononuclear/metabolism , Liver/metabolism , Liver Neoplasms/pathology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Neoplasm Metastasis , Spleen/cytology , Spleen/metabolism , Thymocytes/cytologyABSTRACT
ABSTRACT: Cholesterol granuloma (CG) occurs primarily in the middle ear and rarely in the paranasal sinus. We report an unusual case of paranasal sinus CG with 18F-FDG uptake. A 76-year-old man presented with right refractory epistaxis. PET/CT showed FDG uptake in the maxillary sinus. CT findings are typically uncharacteristic, whereas MRI scans are characterized by a high signal on both T1-weighted and T2-weighted images. Nasal endoscopy from the ostium revealed a granulomatous lesion with hemorrhage at the base of the maxillary sinus. After pathological examination by endoscopic sinus surgery, the patient was diagnosed with CG.
Subject(s)
Cholesterol/metabolism , Fluorodeoxyglucose F18/metabolism , Granuloma/diagnostic imaging , Granuloma/metabolism , Maxillary Sinus/diagnostic imaging , Positron Emission Tomography Computed Tomography , Aged , Biological Transport , Endoscopy , Granuloma/surgery , Humans , Magnetic Resonance Imaging , MaleSubject(s)
Anaphylaxis/chemically induced , Maltose/adverse effects , Anaphylaxis/diagnosis , Anaphylaxis/immunology , Humans , Influenza, Human/drug therapy , Infusions, Intravenous , Male , Maltose/administration & dosage , Maltose/immunology , Patch Tests , Ringer's Lactate/administration & dosage , Ringer's Lactate/adverse effects , Ringer's Lactate/chemistry , Sodium Salicylate/administration & dosage , Vitamin U/administration & dosage , Young AdultABSTRACT
The vitamin D receptor (VDR) is a nuclear receptor for the active form of vitamin D, 1α,25-dihydroxyvitamin D3 , and regulates various physiologic processes, such as bone and calcium metabolism, cellular proliferation and differentiation, and immunity. VDR is highly expressed in the intestine, kidney, bone, and macrophages, but is expressed at a low level in the liver. The liver is a major metabolic organ and also acts as an immune gateway for dietary nutrients and xenobiotics. In this study, we investigated the function of VDR in hepatic immune cells, such as Kupffer cells/macrophages, utilizing VDR knockout (KO) mice. We showed that VDR is functionally expressed in hepatic mononuclear cells, specifically resident Kupffer cells. We examined the role of VDR in acute hepatitis induced by concanavalin A (Con-A) and found that Con-A-induced hepatitis is attenuated in VDR-KO mice compared to wild-type (WT) mice. Con-A-induced hepatitis is known to be mediated by NKT cell activation, cytokine production, and reactive oxygen species (ROS) production in Kupffer cells/macrophages. However, the proportions of Kupffer cells/macrophages and the NKT cell activation were similar in the liver of WT and VDR-KO mice and inflammatory cytokine gene expression was increased in VDR-KO mice. On the other hand, plasma and hepatic ROS levels were decreased in the liver of VDR-KO mice compared to WT mice. The phagocytic activity of resident Kupffer cells and hepatic neutrophils were also decreased in VDR-KO mice. Therefore, VDR is necessary for Con-A-induced acute hepatitis and plays an important role in hepatic immune cell functions.
Subject(s)
Hepatitis/immunology , Leukocytes, Mononuclear/immunology , Receptors, Calcitriol/deficiency , Acute Disease , Animals , Concanavalin A , Cytokines/biosynthesis , Gene Expression Regulation , Inflammation/genetics , Inflammation/pathology , Inflammation Mediators/metabolism , Kupffer Cells/pathology , Liver/immunology , Liver/pathology , Mice, Inbred C57BL , Mice, Knockout , NADPH Oxidases/genetics , NADPH Oxidases/metabolism , Phagocytosis , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reactive Oxygen Species/blood , Receptors, Calcitriol/metabolismABSTRACT
The liver X receptors (LXRs), LXRα and LXRß, are nuclear receptors that regulate lipid homeostasis. LXRs also regulate inflammatory responses in cultured macrophages. However, the role of LXRs in hepatic immune cells remains poorly characterized. We investigated the role of LXRs in regulation of inflammatory responses of hepatic mononuclear cells (MNCs) in mice. Both LXRα and LXRß were expressed in mouse hepatic MNCs and F4/80+ Kupffer cells/macrophages. LXRα/ß-knockout (KO) mice had an increased number of hepatic MNCs and elevated expression of macrophage surface markers and inflammatory cytokines compared to wild-type (WT) mice. Among MNCs, F4/80+CD11b+ cells, not F4/80+CD11b- or F4/80+CD68+ cells, were increased in LXRα/ß-KO mice more than WT mice. Isolated hepatic MNCs and F4/80+CD11b+ cells of LXRα/ß-KO mice showed enhanced production of inflammatory cytokines after stimulation by lipopolysaccharide or CpG-DNA compared to WT cells, and LXR ligand treatment suppressed lipopolysaccharide-induced cytokine expression in hepatic MNCs. Lipopolysaccharide administration also stimulated inflammatory cytokine production in LXRα/ß-KO mice more effectively than WT mice. Thus, LXR deletion enhances recruitment of F4/80+CD11b+ Kupffer cells/macrophages and acute immune responses in the liver. LXRs regulate the Kupffer cell/macrophage population and innate immune and inflammatory responses in mouse liver.
Subject(s)
CD11 Antigens/metabolism , Immunity, Innate , Kupffer Cells/metabolism , Liver X Receptors/metabolism , Liver/metabolism , Macrophages/metabolism , Acute Disease , Animals , Biomarkers/metabolism , Chemokine CCL2/genetics , Chemokine CCL2/metabolism , Gene Deletion , Inflammation/genetics , Inflammation/pathology , Ligands , Lipid Metabolism , Lipids/blood , Mice, Inbred C57BL , Mice, Knockout , RNA, Messenger/genetics , RNA, Messenger/metabolismSubject(s)
Carcinoma in Situ/diagnosis , Carcinoma, Squamous Cell/diagnosis , Conjunctival Neoplasms/diagnosis , Neoplasms, Second Primary/diagnosis , Adult , Cancer Survivors , Carcinoma in Situ/pathology , Carcinoma in Situ/surgery , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/surgery , Conjunctival Neoplasms/pathology , Conjunctival Neoplasms/surgery , Eye Enucleation , Female , Humans , Male , Neoplasms, Second Primary/pathology , Neoplasms, Second Primary/surgery , Retinal Neoplasms/surgery , Retinoblastoma/surgeryABSTRACT
Liver X receptor (LXR) α expression is mainly localized to metabolic tissues, such as the liver, whereas LXRß is ubiquitously expressed. LXRα is activated by oxysterols and plays an important role in the regulation of lipid metabolism in metabolic tissues. In macrophages, LXRs stimulate reverse cholesterol transport and regulate immune responses. Although a high-cholesterol diet induces severe steatohepatitis in LXRα-knockout (KO) mice, the underlying mechanisms linking lipid metabolism and immune responses remain largely unknown. In this study, we investigated the role of LXRα in the pathogenesis of steatohepatitis by assessing the effects of a high-fat and high-cholesterol diet (HFCD) on hepatic immune cell proportion and function as well as lipid metabolism in wild-type (WT) and LXRα-KO mice. HFCD feeding induced severe steatohepatitis in LXRα-KO mice compared with WT mice. These mice had higher cholesterol levels in the plasma and the liver and dysregulated expression of LXR target and proinflammatory genes in both whole liver samples and isolated hepatic mononuclear cells. Flow cytometry showed an increase in CD68+CD11b+ Kupffer cells/macrophages and a decrease in invariant natural killer T cells in the liver of HFCD-fed LXRα-KO mice. These mice were more susceptible to lipopolysaccharide-induced liver injury and resistant to inflammatory responses against α-galactosylceramide or concanavalin-A treatment. The findings provide evidence for activation of bone marrow-derived Kupffer cells/macrophages and dysfunction of invariant natural killer T cells in LXRα-KO mouse liver. These findings indicate that LXRα regulates hepatic immune function along with lipid metabolism and protects against the pathogenesis of nonalcoholic steatohepatitis.
Subject(s)
Fatty Liver/immunology , Kupffer Cells/immunology , Liver X Receptors/genetics , Liver X Receptors/immunology , Macrophages/immunology , Natural Killer T-Cells/immunology , Animals , Cholesterol/metabolism , Fatty Liver/genetics , Humans , Kupffer Cells/metabolism , Liver/immunology , Liver/metabolism , Liver X Receptors/deficiency , Macrophages/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Natural Killer T-Cells/metabolismABSTRACT
We hypothesized that a large number of circulating tumor cells(CTCs)may be isolated from samples obtained by using the leukapheresis procedures that are utilized to collect peripheral blood mononuclear cells for dendritic cell vaccine therapy. We utilized the CellSearch System to determine the number of CTCs in samples obtained by using leukapheresis in 7 patients with colorectal cancer, 5 patients with breast cancer, and 3 patients with gastric cancer. In all patients, a large number of CTCs were isolated. The mean number of CTCs per tumor was 17.1(range 10-34)in colorectal cancer, 10.0(range 2-27)in breast cancer, and 24.0(range 2-42)in gastric cancer. We succeeded in culturing the isolated CTCs from 7 patients with colorectal cancer, 5 patients with breast cancer, and 3 patients with gastric cancer. In conclusion, compared to conventional methods, a large number of CTCs can be obtained by using leukapheresis procedures. The molecular analyses of the CTCs isolated by using this method should be promising in the development of personalized cancer treatments.
Subject(s)
Cell Separation/methods , Leukapheresis/methods , Neoplastic Cells, Circulating , Aged , Breast Neoplasms/pathology , Cells, Cultured , Colonic Neoplasms/pathology , Female , Humans , Male , Middle Aged , Neoplastic Cells, Circulating/pathology , Stomach Neoplasms/pathologyABSTRACT
Growing evidence suggests that pretransplant alpha-fetoprotein (AFP) predicts outcomes of hepatocellular carcinoma (HCC) patients treated with liver transplantation. We aimed to determine whether pretransplant AFP, Lens culinaris agglutinin-reactive alpha-fetoprotein (AFP-L3), and des-gamma-carboxyprothrombin (DCP) predicted HCC recurrence after transplantation. A retrospective cohort study of 313 HCC patients undergoing transplantation between 2000 and 2008 was conducted, and 48 (15.3%) developed recurrence during a median follow-up of 90.8 months. The 127 patients with available serum drawn before transplantation were included; they included 86 without recurrence and 41 with recurrence. Serum was tested for AFP, AFP-L3%, and DCP in a blinded fashion with the µTASWako i30 immunoanalyzer. All biomarkers were significantly associated with HCC recurrence. The hazard ratios (HRs) were 3.5 [95% confidence interval (CI), 1.9-6.7; P < 0.0001] for DCP ≥ 7.5 ng/mL and 2.8 (95% CI, 1.4-5.4; P = 0.002) for AFP ≥ 250 ng/mL. The HR increased to 5.2 (95% CI, 2.3-12.0; P < 0.0001) when AFP ≥ 250 ng/mL and DCP ≥7.5 ng/mL were considered together. When they were combined with the Milan criteria, the HR increased from 2.6 (95% CI, 1.4-4.7; P = 0.003) for outside the Milan criteria to 8.6 (95% CI, 3.0-24.6; P < 0.0001) for outside the Milan criteria and AFP ≥ 250 ng/mL and to 7.2 (95% CI, 2.8-18.1; P < 0.0001) for outside the Milan criteria and DCP ≥7.5 ng/mL. Our findings suggest that biomarkers are useful for predicting the risk of HCC recurrence after transplantation. Using both biomarkers and the Milan criteria may be better than using the Milan criteria alone in optimizing the decision of liver transplantation eligibility.
Subject(s)
Carcinoma, Hepatocellular/diagnosis , Carcinoma, Hepatocellular/surgery , Liver Neoplasms/diagnosis , Liver Neoplasms/surgery , Liver Transplantation/methods , Neoplasm Recurrence, Local/diagnosis , Aged , Biomarkers/metabolism , Carcinoma, Hepatocellular/pathology , Cohort Studies , Female , Humans , Liver Neoplasms/pathology , Male , Middle Aged , Neoplasm Recurrence, Local/pathology , Plant Lectins/chemistry , Proportional Hazards Models , Protein Precursors/metabolism , Prothrombin/metabolism , Retrospective Studies , Severity of Illness Index , Signal Transduction , Tomography, X-Ray Computed/methods , alpha-Fetoproteins/metabolismABSTRACT
Internal symmetry is a common feature of the tertiary structures of proteins and protein domains. Probably, because the genes of homo-oligomeric proteins duplicated and fused, their evolutionary descendants are proteins with internal symmetry. To identify any advantages that cause monomeric proteins with internal symmetry to be selected evolutionarily, we characterized some of the physical properties of a recombinant protein with a sequence consisting of two tandemly fused copies of the Escherichia coli Lac repressor C-terminal alpha-helix. This polypeptide exists in solution mainly as dimer that likely maintains a four-helix bundle motif. Thermal unfolding experiments demonstrate that the protein is considerably more stable at elevated temperatures than is a homotetramer consisting of four non-covalently associated copies of a 21-residue polypeptide similar in sequence to that of the Lac repressor C-terminal alpha-helix. A tandem duplication of our helix-loop-helix polypeptide yields an even more thermally stable protein. Our results exemplify the concept that fusion of non-covalently assembled polypeptide chains leads to enhanced protein stability. Herein, we discuss how our work relates to the evolutionary selective-advantages realized when symmetrical homo-oligomers evolve into monomers. Moreover, our thermally stable single-chain four-helix bundle protein may provide a robust scaffold for development of new biomaterials.
Subject(s)
Evolution, Molecular , Helix-Loop-Helix Motifs , Peptides/chemistry , Protein Stability , Escherichia coli/genetics , Gene Duplication , Lac Repressors/chemistry , Lac Repressors/genetics , Models, Molecular , Peptides/genetics , Protein Multimerization , Protein Structure, Tertiary , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , TemperatureABSTRACT
Silver(I) oxalate, Ag2(C2O4), reacts with two equivalents of oleylamine (Ag:oleylamine = 1:1 mole/mole) to form an oxalate-bridged silver-oleylamine complex, [(oleylamine)Ag(micro-C2O4)Ag(oleylamine)]. The precursor complex is thermally decomposed at approximately 150 degrees C with CO2 evolution to produce Ag nanoparticles with approximately 11 nm dimension. The Ag nanoparticles contain approximately 12 wt% of oleylamines as the surface stabilizer. In the synthetic mechanism, the oxalate ligand acts as a two-electron reducing agent. The precursor complex is directly transformed into oleylamine-stabilized Ag nanoparticles in high yields of more than 80% without any additional synthetic organic solvents and reducing agents.
ABSTRACT
The pulmonary complications of end-stage liver disease include hepatopulmonary syndrome and portopulmonary hypertension. The etio-pathogenesis of these conditions is as yet unclear. Hepatopulmonary syndrome is a gas exchange abnormality and usually manifests as hypoxemia secondary to intra-pulmonary vascular shunts. These shunts can be demonstrated by echocardiography using agitated saline injections, and quantitated by lung perfusion scans. Liver transplantation is the treatment of choice for hepatopulmonary syndrome, and there are no effective pharmacological therapies. Portopulmonary hypertension is a hemodynamic problem which manifests as fatigue and right sided cardiac failure. Several vasoactive agents have been used to lower mean pulmonary arterial pressures. Portopulmonary hypertension is a relative contraindication to liver transplantation.
ABSTRACT
A 35-year-old woman was admitted to our hospital for right upper quadrant pain and multiple liver tumor were detected by diagnostic imaging. Tumors located near the surface of the liver which accompanied capsular retraction. Diagnostic laparoscopy showed multiple white tone tumors with retraction of the adjacent liver capsule. Tumor targeted biopsy was performed. The pathologic diagnosis of epithelioid hemangioendothelioma (EHE) was made by the positive staining of factor VIII-related antigen. EHE tend to locate in peripheral and extend to the liver capsule. Therefore, we face difficulties in getting biopsy sample safely. Here we report a useful case of laparoscopic examination and biopsy in the diagnosis of EHE.
Subject(s)
Hemangioendothelioma, Epithelioid/diagnosis , Hemangioendothelioma, Epithelioid/pathology , Laparoscopy , Liver Neoplasms/diagnosis , Liver Neoplasms/pathology , Adult , Biopsy/methods , Diagnosis, Differential , Diagnostic Imaging , Female , Humans , Liver/pathologyABSTRACT
BACKGROUND & AIMS: Clinical significance of molecules involving innate immunity in treatment response remains unclear. The aim is to elucidate the mechanisms underlying resistance to antiviral therapy and predictive usefulness of gene quantification in chronic hepatitis C (CH-C). METHODS: We conducted a human study in 74 CH-C patients treated with pegylated interferon alpha-2b and ribavirin and 5 nonviral control patients. Expression of viral sensors, adaptor molecule, related ubiquitin E3-ligase, and modulators were quantified. RESULTS: Hepatic RIG-I, MDA5, LGP2, ISG15, and USP18 in CH-C patients were up-regulated at 2- to 8-fold compared with nonhepatitis C virus patients with a relatively constitutive Cardif. Hepatic RIG-I, MDA5, and LGP2 were significantly up-regulated in nonvirologic responders (NVR) compared with transient (TR) or sustained virologic responders (SVR). Cardif and RNF125 were negatively correlated with RIG-I and significantly suppressed in NVR. Differences among clinical responses in RIG-I/Cardif and RIG-I/RNF125 ratios were conspicuous (NVR/TR/SVR = 1.3:0.6:0.4 and 2.3:1.3:0.8, respectively). Like viral sensors, ISG15 and USP18 were significantly up-regulated in NVR (4-fold and 2.3-fold, respectively). Multivariate and receiver operator characteristic analyses revealed higher RIG-I/Cardif ratio, ISG15, and USP18 predicted NVR. Lower Cardif in NVR was confirmed by its protein level in Western blot. Also, transcriptional responses in peripheral blood mononuclear cells to the therapy were rapid and strong except for Cardif in not only a positive (RIG-I, ISG15, and USP18) but also in a negative regulatory manner (RNF125). CONCLUSIONS: NVR may have adopted a different equilibrium in their innate immune response. High RIG-I/Cardif and RIG-I/RNF125 ratios and ISG15 and USP18 are useful in identifying NVR.
Subject(s)
Antiviral Agents/therapeutic use , Biomarkers/analysis , Hepacivirus/immunology , Hepatitis C, Chronic/immunology , Immunity, Innate/physiology , Interferon-alpha/therapeutic use , Ribavirin/therapeutic use , Blotting, Western , Drug Resistance, Viral/physiology , Drug Therapy, Combination , Female , Follow-Up Studies , Gene Expression Regulation , Hepatitis C, Chronic/drug therapy , Humans , Interferon alpha-2 , Male , Middle Aged , Polyethylene Glycols , Polymerase Chain Reaction , ROC Curve , Recombinant ProteinsABSTRACT
BACKGROUND/AIMS: Interferon (IFN) therapy leads to regression of hepatic fibrosis in chronic hepatitis C patients who achieve a sustained virologic response (SVR), while the beneficial effect is limited in those who fail to do so. The aim of the present study was to define factors associated with progression of fibrosis in patients who do not achieve a SVR. METHODS: Fibrosis staging scores were compared between paired liver biopsies before and after IFN in 97 chronic hepatitis C patients who failed therapy. The mean interval between biopsies was 5.9 years. Factors associated with progression of fibrosis were analyzed. RESULTS: Fibrosis progressed in 23%, remained unchanged in 47% and regressed in 29%. Steatosis and a high average alanine aminotransferase (ALT) between biopsies were independent factors for progression of fibrosis with risk ratios of 5.53 and 4.48, respectively. Incidence and yearly rate of progression of fibrosis was 64% and 0.22+/-0.29 fibrosis units per year in those with both risk factors compared to 8% and -0.04+/-0.17 fibrosis units per year in those negative for both factors. CONCLUSIONS: Hepatic steatosis and elevated ALT levels are risk factors for progression of fibrosis in chronic hepatitis C patients who fail to achieve a SVR to IFN therapy and therefore may be therapeutic targets to halt the potentially progressive disease.